François Danion
Hôpitaux Universitaires de Strasbourg(FR)Université de Strasbourg(FR)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, Antifungal resistance and susceptibility, SARS-CoV-2 and COVID-19 Research, Fungal Infections and Studies, Long-Term Effects of COVID-19
Most-Cited Works
- → Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial(2021)340 cited
- → Is COVID-19 infection more severe in kidney transplant recipients?(2020)263 cited
- → Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial(2022)157 cited
- → Disease Entities in Mucormycosis(2019)148 cited
- → Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study(2023)130 cited
- → Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020(2020)128 cited
- → Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort(2021)123 cited
- → An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19(2021)106 cited
- → CT lung lesions as predictors of early death or ICU admission in COVID-19 patients(2020)83 cited
- → Mucormycosis: New Developments into a Persistently Devastating Infection(2015)76 cited